Concepedia

CRISPR-based in situ engineering tumor cells to reprogram macrophages for effective cancer immunotherapy

Meng Lin, Zhenzhen Yang, Yiliang Yang, Yiwei Peng, Jiajia Li, Yitian Du, Qi Sun, Datong Gao, Quan Yuan, Yu Zhou,

Nano Today · 2021 · 56 citations · 38 references

DOI

Concepts

References

38

Multiplex Genome Engineering Using CRISPR/Cas Systems

Le Cong, F. Ann Ran, David Cox et al. · Science · 2013 · 15.7K citations

, , +16

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

Tyler J. Curiel, George Coukos, Linhua Zou et al. · Nature Medicine · 2004 · 5.1K citations

, , +16

High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects

Benjamin P. Kleinstiver, Vikram Pattanayak, Michelle S. Prew et al. · Nature · 2016 · 2.7K citations · Full text

, , +14

Easy quantitative assessment of genome editing by sequence trace decomposition

Eva K. Brinkman, Tao Chen, Mario Amendola et al. · Nucleic Acids Research · 2014 · 2.6K citations · Full text

, , +13

Rationally engineered Cas9 nucleases with improved specificity

Ian M. Slaymaker, Linyi Gao, Bernd Zetsche et al. · Science · 2015 · 2.5K citations

, , +15